CRISPR Therapeutics AG(CRSP US)
$54.11+2.645.13%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 370.0 | 35.0 | 3.5 | 4.1 | |||||||||||
| -Cost of Revenue | 130.3 | 110.3 | 233.0 | 224.1 | |||||||||||
| Gross Profit | 239.8 | -75.3 | -229.4 | -220.0 | |||||||||||
| -Operating Expenses | 462.3 | 391.3 | 338.9 | 330.2 | |||||||||||
| +Selling, General & Admin | 76.2 | 73.0 | 73.5 | 71.4 | |||||||||||
| +General And Administrative Expenses | 76.2 | 73.0 | 73.5 | 71.4 | |||||||||||
| +Research and Development | 387.3 | 320.7 | 265.3 | 270.6 | |||||||||||
| +Other Operating Expenses | -1.2 | -2.3 | - | -11.9 | |||||||||||
| Operating Income | -222.5 | -466.6 | -568.3 | -550.1 | |||||||||||
| +Non Operating Income | 71.8 | 103.9 | -9.6 | -15.0 | |||||||||||
| +Interest Income, Net | - | - | - | - | |||||||||||
| +Interest Income | - | - | - | - | |||||||||||
| -Interest Expense | - | - | - | - | |||||||||||
| +Other Non-Op Income | 71.8 | 103.9 | -9.6 | -15.0 | |||||||||||
| Pretax Income | -150.7 | -362.7 | -578.0 | -565.2 | |||||||||||
| -Income Tax Expense | 2.9 | 3.6 | 3.6 | 3.4 | |||||||||||
| Income from Cont Ops | -153.6 | -366.3 | -581.6 | -568.5 | |||||||||||
| -Net Extraordinary Losses | - | - | - | - | |||||||||||
| +Discounted operations | - | - | - | - | |||||||||||
| +XO & Accounting Changes | - | - | - | - | |||||||||||
| Income Incl. MI | -153.6 | -366.3 | -581.6 | -568.5 | |||||||||||
| -Minority Interests | - | - | - | - | |||||||||||
| Net Income, GAAP | -153.6 | -366.3 | -581.6 | -568.5 | |||||||||||
| -Prfrrd Div & Other | - | - | - | - | |||||||||||
| Net Income Avail To Common | -153.6 | -366.3 | -581.6 | -568.5 | |||||||||||
| Weighted Average Shs Out | 79,220,930.0 | 84,359,126.0 | 89,925,109.0 | 364,351,364.0 | |||||||||||
| EPS | -1.9 | -4.3 | -6.5 | -6.2 | |||||||||||
| Weighted Average Shs Out Dil | 79,220,930.0 | 84,359,126.0 | 89,925,109.0 | 364,351,364.0 | |||||||||||
| EPS Diluted | -1.9 | -4.3 | -6.5 | -6.2 | |||||||||||